The FDA has announced a research collaboration that will focus on the safety of drugs given to pregnant women. The Medication Exposure in Pregnancy Risk Evaluation Program was prompted by concerns about insufficient clinical trials on the issue at a time when two-thirds of women reportedly take at least one prescription drug during pregnancy.

Full Story:

Related Summaries